|
DOSING: Injectable calcitonin is injected under the skin or into the muscle. The nasal spray is administered into the nostril. To achieve optimal results, ... The nausea that can occur with injectable calcitonin is unlikely to occur with the nasal spray. In rare instances, the nasal spray can cause an upset stomach.
|
www.medicinenet.com/calcitonin/article.htm
www.medicinenet.com/calcitonin/article.htm
|
|
|
|
The approval of more efficacious agents should make Miacalcin one of last resort as an osteoporosis treatement. ... In 1994, the FDA advisory, after evaluating numerous small trials, such as the one above, advised approval of calcitonin nasal spray as they felt that the potential benefits outweighed the risks.
|
www.healthcentral.com/osteoporosis/c/73/57448/miacalcin...
www.healthcentral.com/osteoporosis/c/73/57448/miacalcin-nasal
|
|
|
Physician reviewed calcitonin nasal patient information - includes calcitonin nasal description, dosage and directions. ... To prime calcitonin nasal, spray the medicine into the air and away from your face, until a fine mist appears. You will need to prime the pump only before your first use of the newly assembled bottle.
|
www.drugs.com/mtm/calcitonin-nasal.html
www.drugs.com/mtm/calcitonin-nasal.html
|
|
SUBJECTS AND METHODS: A total of 1,255 postmenopausal women with established osteoporosis were randomly assigned to receive salmon calcitonin nasal spray (100, 200, or 400 IU) or placebo daily. All participants received elemental calcium (1,000 mg) and vitamin D (400 IU) daily.
|
www.ncbi.nlm.nih.gov/pubmed/10996576
|
|
Calcitonin Nasal Spray (Miacalcin): There are, at present, no large-scale, prospective, double-blind, placebo-controlled, randomized clinical trials to determine the efficacy of estrogen in reducing the fracture risk of patients with osteoporosis. ... Calcitonin nasal spray should be refrigerated.
|
www.medscape.com/viewarticle/410801_3
|
|
Miacalcin® nasal spray (calcitonin salmon nasal spray) is a prescription medication used for osteoporosis. It is approved to treat the condition in postmenopausal women who are at least five years past menopause.
|
osteoporosis.emedtv.com/miacalcin-nasal-spray/miacalcin...
osteoporosis.emedtv.com/miacalcin-nasal-spray/miacalcin-nasal-spray.html
|
|
News release from the University of Washington Health Sciences ... 14, 1998 – A recently completed study shows that calcitonin-salmon nasal spray reduced by 36 percent the incidence of new spinal fractures in postmenopausal women with osteoporosis.
|
www.washington.edu/newsroom/news/1998archive/09-98archi...
www.washington.edu/newsroom/news/1998archive/09-98archive/k092298a.html
|
|
In September 1999, Health Canada approved Miacalcin NS 200 IU (international units), as the first nasal spray treatment for osteoporotic women who are at least five years into their menopause.
|
www.pslgroup.com/dg/1e1eb6.htm
|
|
Our US Pharmaceuticals portfolio includes key marketed products, ... Key pharmaceutical products marketed by Novartis in the US are listed below by therapeutic area, ... Important Information:; Disease categories and product names are listed for your convenience in searching for and finding information about Novartis offerings.
|
www.pharma.us.novartis.com/products/index.jsp
|
|
